News & Features
Just as Amazon’s complex algorithms predict the purchases you’re most likely to enjoy, big data may enable us to tailor treatment and screening decisions based on predictions about your health. Read more on the Leading the Change blog.
New research in Alzheimer’s disease focuses on a protein that interrupts signals between brain cells and may point to a new direction in treatment.
In re-evaluating hallucinogenic drugs, psychopharmacologists Matthew Johnson and Roland Griffiths have discovered psilocybin’s potential to treat various disorders, including obsessive-compulsive disorder and inflammatory disease.
Researchers have designed a thin, biodegradable plastic coating for metal implants that can release multiple antibiotics to diminish the chance of infections.